Impact BioMedical, Inc. (AMEX: IBO) last traded at $4.25, up 3.41% on the session. The quote above updates while this page is open; the figures below are drawn from Impact BioMedical, Inc.’s own filings and are restated only when a new one is published.
Impact BioMedical, Inc. trades on AMEX under the ticker IBO. Its market capitalisation is $458.24 million.
Valuation measures for Impact BioMedical, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $458.24M |
|---|---|
| Enterprise value | $460.95M |
| Price / sales | 14320.01 |
| Price / book | 42.56 |
| Beta | -0.89 |
Trailing-twelve-month figures tagged in Impact BioMedical, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $32.0K |
|---|---|
| Net income (TTM) | $789.0K |
| Gross margin | -1225.00% |
| Operating margin | -15968.75% |
| Return on equity | 7.33% |
| Cash | $20.0K |
Range and volume for IBO over the past 52 weeks.
| 52-week high | $10.51 |
|---|---|
| 52-week low | $4.06 |
| Volume | 4.0K |
| Average volume | 11.7K |
| Previous close | $4.11 |
Invest a chosen dollar amount in Impact BioMedical, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell IBO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.